These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets. Luo G; Kong X; Lu L; Xu X; Wang H; Ma X Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045 [TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 and islet lipolysis. Sörhede Winzell M; Ahrén B Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711 [TBL] [Abstract][Full Text] [Related]
5. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699 [TBL] [Abstract][Full Text] [Related]
6. Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets. Sloop KW; Willard FS; Brenner MB; Ficorilli J; Valasek K; Showalter AD; Farb TB; Cao JX; Cox AL; Michael MD; Gutierrez Sanfeliciano SM; Tebbe MJ; Coghlan MJ Diabetes; 2010 Dec; 59(12):3099-107. PubMed ID: 20823098 [TBL] [Abstract][Full Text] [Related]
8. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703 [TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604 [TBL] [Abstract][Full Text] [Related]
11. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells. Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905 [TBL] [Abstract][Full Text] [Related]
12. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction. Fehmann HC; Bode HP; Ebert T; Karl A; Göke B Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558 [TBL] [Abstract][Full Text] [Related]
15. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line. Fehmann HC; Habener JF FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839 [TBL] [Abstract][Full Text] [Related]
17. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes. Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903 [TBL] [Abstract][Full Text] [Related]
18. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor. Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973 [TBL] [Abstract][Full Text] [Related]
19. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency. Chen M; Mema E; Kelleher J; Nemechek N; Berger A; Wang J; Xie T; Gavrilova O; Drucker DJ; Weinstein LS Endocrinology; 2011 Sep; 152(9):3343-50. PubMed ID: 21771891 [TBL] [Abstract][Full Text] [Related]
20. Function and expression of sulfonylurea, adrenergic, and glucagon-like peptide 1 receptors in isolated porcine islets. Kelly AC; Steyn LV; Kitzmann JP; Anderson MJ; Mueller KR; Hart NJ; Lynch RM; Papas KK; Limesand SW Xenotransplantation; 2014; 21(4):385-91. PubMed ID: 24801676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]